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Introduction
Due to excessive use of lead in industry and
automobile fuel,  human beings have been, and are
constantly being, exposed to it.  Environmental lead
exposure is a public health problem on global level1, as it
adversely affects the function of several organ systems
including cardiovascular, renal, nervous, hemopoietic,
endocrine and skeletal systems.2,3 Although the exact
magnitude of lead poisoning in Pakistan is not known, some
sporadic studies have indicated that the levels in population
are much above the safety levels (10 mg/dL) recommended
by the United States Center for Disease Control and
Prevention (CDC). Mean blood lead levels were reported to
be 18.8 mg/dL (5.0-38.8 mg/dL) in children in Rawalpindi4
and 34.4, 31.8, 29.9 and 38.2 mg/dL in males, females,
soldiers and children, respectively, from Karachi.5 Of these,
over 90% population had levels above the safety limit.
More recently, more than 80% children from Karachi were
found to have lead levels above 10 mg/dL.6
Lead gets into the body through food, water and air.
Environmental pollution, agricultural technology and food
processing are the main sources of exposure.7 Absorption
and retention in the body depends on age, chemical
environment of the gastrointestinal tract and nutritional
status of the individual.  Generally, conditions that favor
calcium absorption also favor lead absorption and retention.
The total body content of lead does not affect its absorption,
as there is no feed back mechanism for its absorption.7 The
mean biological life of lead in blood is about 30 days8, after
which majority (70-95%) of it is accumulated within the
long-lived compartments of bones, with the elimination
half-life of 5-10 years.9
The increased nutritional requirements during
pregnancy and the pregnancy-induced homeorhesis may
result in elevated blood lead levels.  During pregnancy
stores of lead deposited in bones over lifetime may be
mobilized, particularly in those whose calcium intake is
low.10-12 Mobilization from bones depends on maternal age,
overall nutritional status, parity, race and gestational age.11
In addition, absorption from the gut may be increased.
Since placenta does not offer any restrictive barrier to the
transfer    of lead from maternal blood  to the  fetal blood10,13-16,
the developing fetus may be exposed to the adverse effects
of lead.  
The effects of high blood lead levels on pregnancy
outcome has been thoroughly investigated and reviewed.
Children born to women with high lead levels are usually
smaller, weaker, slower in development, and have a higher
infant mortality.11 High lead levels during pregnancy are
associated consistently with increased spontaneous
abortion, still birth, premature birth, and neonatal deaths.10
Low levels of exposure have shown inconsistent results
with birth weight and prematurity.10,11 The results vary from
no effect to mild, statistically non-significant association, to
a significant dose dependent effect.10,11,17,18 The reasons for
the inconsistency are differences in the lead levels, stage of
gestation in which blood samples were taken, and whether
association was determined with maternal or fetal blood
lead levels.  
Poor pregnancy outcomes like miscarriage, stillbirths,
intrauterine growth retardation and low birth weight are fairly
common in this country.19,20 How much of these problems are
associated with high lead levels is not known and is worth
investigating. The purpose of this study was thus to investigate
the association of blood lead levels during pregnancy with
pregnancy outcome in a population of women from Karachi,
where lead levels are presumably high from heavy industries
and heavy traffic using leaded gasoline.
Materials and Methods
Subject Selection 
This study was conducted at the Jinnah Postgraduate
Medical Center, Obstetrics and Gynecology unit.  Women
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who were brought to the clinic for labour between 09:00 and
14:00 hours over a period of four weeks were sequentially
recruited after obtaining their verbal informed consent.
Weight and height of the mothers were recorded to the
nearest 0.1 Kg and 0.1 centimeter, respectively, using the
standard techniques.  5 ml of the venous blood was drawn
in heparinised vaccutainers and was stored at 4°C for lead
analysis. After delivery, birth weight of neonate was
recorded to the nearest 10 grams and recumbent length
(crown-heel length) and head circumference were measured
to the nearest 0.1 centimeter, using non-stretchable tape.
Gestational age was calculated from the first day of the last
menstrual period, if known, or by asking mothers the age of
the fetus in months.  Term deliveries, reported by some
mothers, were considered as 40 weeks of gestation.  Data
were recorded on a total of 75 mother-fetus pairs.
Analysis of lead
Lead content in whole blood was determined at the
Pakistan Council for Scientific and Industrial Research
(PCSIR) laboratories, Karachi, Pakistan.  The CDC, USA,
provided quality control for analyses. Lead was analyzed by
Hitachi polarized Zeeman atomic absorption
spectrophotometer, (model Z-800, Hitachi, Tokyo, Japan)
with a graphite furnace.  The instrument was calibrated with
lead standards (lead nitrate, 1000 mg/dL, Cat. # 45556,
BDH, Dorset, England) by the standard addition method as
described by Miller et al.21 The instrument specification are
given in table 1.
Samples and standards were prepared with a matrix
modifier solution which contained 0.5% v/v Triton X-100,
0.2% v/v 65% (16 M) extra pure nitric acid and 0.2%
dibasic ammonium phosphate21 all from Sigma Chemical
Co. (St. Louis, MO).  Water used for reagents preparation
was purified to approximately 18 M W/cm with a Milli-Q
system (Millipore).
Statistical analyses
The data was analyzed with Statistical Package for
Social Sciences (SPSS) software (version 8.0) for windows.
Univariate and multivariate regression analyses were
carried out to measure the association of maternal blood
lead with gestational age, birth weight, birth length and head
circumference. In multivariate regression analyses,
variables with no significant effect were removed from the
full model in a step-wise manner and the data presented is
for only the best models.  Group comparisons between boys
and girls were estimated with the Student's t-test.  The level
of significance was set at P <0.05.
Results
Of the 75 mother-fetus pairs included in the study,
one mother gave birth to twins and was excluded from the
study.  Lead levels could be measured in 73 women for
whom the data is presented. Table 2 shows data on mean
Table 1. Instrument specification for lead analysis.
Instrument conditions




Carrier gas 200 ml/min
Interrupted gas 30 ml/min
Sample volume 20 ml
Temperature Program
Temperature (C) Time (Second)
Stage Start End
Dry: 80 120 30.0
Ash: 400 400 30.0
Atom: 2000 2000 10.0
Clean: 2400 2400 3.0
Table 2. Demographic and anthropometric information and blood
lead levels of pregnant women (n = 74) at the time of delivery.
Mean ± SD Range
Age (years) 25.5±4.8 15.0-39.0
Weight (Kg) 57.8±7.0 44.0-81.0
Height (cm) 156.2±8.0 127.5-170.0
Education (number of years) 4.9±4.7 0-12
Number of children before 2.7±1.9 1-9
Blood lead level (mg/dL)* 9.91±4.44 2.28-36.35
* n = 73
Table 3.  Birth weight, recumbent length, head circumference and
gestational age (Mean ± SD) of male and female infants born to
study mothers.
Male Female Total 
(n=37) (n=37) (n=74)
Gestational age (weeks) 39.7±1.8 39.6±1.7 39.6±1.8
Birth Weight (gm) 2793±547 2650±427 2722±493
Recumbent length (cm) 51.1±4.6 52.0±4.0 51.5±4.3
Head circumference (cm) 32.5±3.0 32.1±2.7 32.3±2.8
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age, body weight, height, number of previous births
(parity), years of education and their blood lead levels.
Mean blood lead levels were 9.91±4.44 mg/dL. The mean
(±SD) gestational age (weeks), birth weight (grams),
recumbent length (cm) and head circumference (cm) of
infants born to the study mothers were 39.6±1.8, 2722±493,
51.5±4.3 and 32.3±2.8, respectively (Table 3).
No difference was observed in gestational age, birth
weight, recumbent length and head circumference between
boys and girls (Table 3). Univariate regression analysis
showed no association of maternal lead levels at the time of
delivery with any of the growth parameters in new-borns
(Table 4). Of the other variables, maternal weight and
gestational age were significant positive predictor of birth
weight. Head circumference was significantly associated
with gestational age, whereas, significant predictors for
recombent length were maternal height and gestational age.
Number of previous children (parity) had negative
association with all the four outcome variables tested, but
Table 4. Univariate regression analyses of the association of maternal variables with infant outcome variables.
Outcome Variable Maternal Covariates Coefficient (b) R2 p-value
Birth Wieght Blood lead 19.12 3.0 0.146
Age -0.31 0 0.979
Weight 21.27 9.2 0.009
Height 33.25 4.7 0.064
Education -6.13 0.3 0.619
Parity -83.39 10.6 .005
Gestational Age 11.60 8.2 0.013
Head Circumference Blood lead 0.054 0.7 0.477
Age -0.059 1.0 0.395
Weight 0.089 5.0 0.056
Height 0.097 1.2 0.348
Education 0.096 2.6 0.168
Parity -0.373 6.5 0.028
Gestational Age 0.072 9.8 0.007
Recombent Length Blood lead 0.03 0.1 0.796
Age -0.087 0.9 0.410
Weight 0.100 2.7 0.165
Height 0.438 10.7 0.004
Education 0.042 0.2 0.695
Parity -0.329 2.2 0.212
Gestational Age 0.104 8.7 0.011
Gestational Age Blood lead 0.291 1.1 0.375
Age -0.041 2.6 0.174
Weight 0.129 0.6 0.527
Height 0.453 1.4 0.310
Education 0.271 1.1 0.373
Parity -1.424 5.1 0.054
Table 5.  Multivariate regression analyses of the association of
maternal variables with the infant outcome variables.
Outcome variables Model used b p-value R2
Birth weight Age 31.32 0.024 21.4
Parity -116.63 0.001
Gestational age 9.43 0.036
Head circumference Weight 0.080 0.071 15.6
Education 0.079 0.236
Gestational age 0.066 0.012
Recombent length Height 0.397 0.008 17.3
Gestational age 0.092 0.020
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the effect was statistically non-signifcant for recombent
length.   In the multivariate analyses, the effect of gestaional
age on birth weight, head circumference and recumbent
length remained significant after controlling for
confounding variables (Table 5).  The negative effect of
parity on birth weight, and the positive effect of maternal
height also remained significant in the multivariate analyses
(Table 5).  We compared the growth parameters of infants
born to mothers with blood lead levels of <10 mg/dL with
those of mothers with lead levels of  >10 mg/dl, and did not
find any significant difference between the two groups in
any of the parameters (data not shown). Mothers of boys
had statistically significant higher blood lead levels
(11.05±5.19 mg/dL, n=37) when compared to mothers of
girls (8.74±3.18 mg/dL, n=36).  The one-tailed t-statistic of
2.295 gave a P-value of 0.013.
Discussion 
Karachi is a densely populated city with increased
lead burden from environmental pollution.  This is
translated into increased blood lead levels in general
population.5,6 Poor pregnancy outcomes like intrauterine
growth retardation, premature births and high maternal
mortality rate are common in this part of the world. A
positive association has been shown in a number of
published reports between high blood lead levels and poor
pregnancy outcome22,23, but such association has not been
substantiated by other studies. 17,18,24,25 We, therefore,
undertook this study to investigate the association of blood
lead with pregnancy outcome in our population.  
We selected our study sample from maternity clinic
of the Jinnah Postgraduate Medical Centre, as it is a
catchment hospital for a much wider population and attracts
mostly women from relatively low socio-economic status.
These women are more likely to have high blood lead levels
because of increased environmental, occupational and
dietary lead exposure.  
A previous study from Karachi5 reported very high
mean blood lead levels (38 mg/dL) in women.  We
therefore, expected lead levels to be even higher in our
study population because of pregnancy-induced increased
absorption from the gut and increased mobilization from
bones.7,11,12 However, mean blood lead level in our study
sample was much lower than the previously reported blood
lead level from Karachi women.5 This discrepancy could be
explained by two hypotheses: (1) Blood lead level is a
reflection of the current exposure, as most of the lead gets
accumulated in bones after about 30 days.8,9 In pregnancy
the mobility is decreased which may result in decreased
exposure and hence decreased blood lead levels. (2) Blood
volume increases in pregnancy, by as much as 30-40%, and
the relatively lower blood lead levels in pregnant women
that we report here could be due to this dilution effect.
These factors should be considered in future such studies. 
The outcome variables in our study are gestational
age, birth weight, head circumference and crown-heal
length of the fetus. Gestational age is not only an outcome
variable but also a major confounding factor affecting fetal
growth.  One major limitation of our study is the recall bias
in the gestational age, as majority of the women did not
remember the first day of their last menstrual period (LMP),
from which the gestational age should be calculated.  Those
women who did not remember their first day of LMP were
asked whether the index baby is a term delivery or preterm.
Term deliveries were considered as 40 weeks of gestation.
We did not find any association of blood lead with
gestational age, as opposed to findings from several studies
showing a shorter gestational age in women with high lead
levels.17,22,26 This could be explained in many ways.  Firstly,
majority of gestational data in our study is based on the
close approximation of gestational age, as explained earlier,
and there might have been some over-estimation in
reporting gestational age. Secondly, we selected our
subjects in specified times of a day and as such we might
have missed miscarriages and preterm deliveries that had
occurred at other times.  Thirdly, our sample may not be
large enough to pick up the reported association.  Lastly,
individual and racial differences in the effect of lead have
been reported27, which could explain partly lack of the
association in our study population.
We found no association of blood lead with fetal
growth either in terms of birth weight or birth length.
Similarly no association has been reported by a number of
studies.17,18,25,28 A threshold level of 15 mg/dL has been
suggested by Gonzalez-Cossio et al.29 in order to show an
adverse effect on birth weight.  The lower mean blood lead
level in our study population (<10 mg/dL) may explain this
apparent lack of inverse association of blood lead with fetal
growth. 
An interesting observation in our study was that
mothers of boys were found to have significantly higher
mean blood lead levels when compared to mothers of girls.
The physiological relavence of this apparent finding
remains unclear. Lead is known to disturb the normal profile
of reproductive hormones in animals, both at hypothalamic-
pituitary and at the gonadal levels.30-32 Whether lead has
similar effects on human reproduction, remains to be
investigated.
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